Moss Genomics Inc. (CSE:MOSS)
 0.0600
 +0.0050 (9.09%)
  Oct 30, 2025, 10:29 AM EDT
Moss Genomics Statistics
Total Valuation
Moss Genomics has a market cap or net worth of CAD 3.46 million.
| Market Cap | 3.46M | 
| Enterprise Value | n/a | 
Important Dates
| Earnings Date | n/a | 
| Ex-Dividend Date | n/a | 
Share Statistics
Moss Genomics has 57.69 million shares outstanding.
| Current Share Class | 57.69M | 
| Shares Outstanding | 57.69M | 
| Shares Change (YoY) | n/a | 
| Shares Change (QoQ) | n/a | 
| Owned by Insiders (%) | 19.86% | 
| Owned by Institutions (%) | n/a | 
| Float | 46.24M | 
Valuation Ratios
| PE Ratio | n/a | 
| Forward PE | n/a | 
| PS Ratio | n/a | 
| PB Ratio | n/a | 
| P/TBV Ratio | n/a | 
| P/FCF Ratio | n/a | 
| P/OCF Ratio | n/a | 
| PEG Ratio | n/a | 
Enterprise Valuation
| EV / Earnings | n/a | 
| EV / Sales | n/a | 
| EV / EBITDA | n/a | 
| EV / EBIT | n/a | 
| EV / FCF | n/a | 
Financial Position
| Current Ratio | n/a | 
| Quick Ratio | n/a | 
| Debt / Equity | n/a | 
| Debt / EBITDA | n/a | 
| Debt / FCF | n/a | 
| Interest Coverage | n/a | 
Financial Efficiency
| Return on Equity (ROE) | n/a | 
| Return on Assets (ROA) | n/a | 
| Return on Invested Capital (ROIC) | n/a | 
| Return on Capital Employed (ROCE) | n/a | 
| Revenue Per Employee | n/a | 
| Profits Per Employee | n/a | 
| Employee Count | n/a | 
| Asset Turnover | n/a | 
| Inventory Turnover | n/a | 
Taxes
| Income Tax | n/a | 
| Effective Tax Rate | n/a | 
Stock Price Statistics
The stock price has increased by +120.00% in the last 52 weeks. The beta is -14.61, so Moss Genomics's price volatility has been lower than the market average.
| Beta (5Y) | -14.61 | 
| 52-Week Price Change | +120.00% | 
| 50-Day Moving Average | 0.13 | 
| 200-Day Moving Average | n/a | 
| Relative Strength Index (RSI) | 40.74 | 
| Average Volume (20 Days) | 19,534 | 
Short Selling Information
| Short Interest | n/a | 
| Short Previous Month | n/a | 
| Short % of Shares Out | n/a | 
| Short % of Float | n/a | 
| Short Ratio (days to cover) | n/a | 
Income Statement
| Revenue | n/a | 
| Gross Profit | n/a | 
| Operating Income | n/a | 
| Pretax Income | n/a | 
| Net Income | n/a | 
| EBITDA | n/a | 
| EBIT | n/a | 
| Earnings Per Share (EPS) | n/a | 
Balance Sheet
| Cash & Cash Equivalents | n/a | 
| Total Debt | n/a | 
| Net Cash | n/a | 
| Net Cash Per Share | n/a | 
| Equity (Book Value) | n/a | 
| Book Value Per Share | n/a | 
| Working Capital | n/a | 
Cash Flow
| Operating Cash Flow | n/a | 
| Capital Expenditures | n/a | 
| Free Cash Flow | n/a | 
| FCF Per Share | n/a | 
Margins
| Gross Margin | n/a | 
| Operating Margin | n/a | 
| Pretax Margin | n/a | 
| Profit Margin | n/a | 
| EBITDA Margin | n/a | 
| EBIT Margin | n/a | 
| FCF Margin | n/a | 
Dividends & Yields
Moss Genomics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a | 
| Dividend Yield | n/a | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | n/a | 
| Buyback Yield | n/a | 
| Shareholder Yield | n/a | 
| Earnings Yield | n/a | 
| FCF Yield | n/a | 
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a | 
| Lynch Upside | n/a | 
| Graham Number | n/a | 
| Graham Upside | n/a | 
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a | 
| Split Type | n/a | 
| Split Ratio | n/a | 
Scores
| Altman Z-Score | n/a | 
| Piotroski F-Score | n/a |